S'abonner

IgE to cyclophilins in pollen-allergic children: Epidemiologic, clinical, and diagnostic relevance of a neglected panallergen - 05/06/24

Doi : 10.1016/j.jaci.2024.01.030 
Paolo Maria Matricardi, MD a, b, c, , Ekaterina Potapova, MD a, Valentina Panetta, PhD d, Jonas Lidholm, PhD e, Lars Mattsson, PhD e, Enrico Scala, MD f, Roberto Bernardini, MD g, Carlo Caffarelli, MD h, Antonella Casani, MD i, Rosa Cervone, MD g, Loredana Chini, MD j, Pasquale Comberiati, MD k, Giovanna De Castro, MD l, Michele Miraglia del Giudice, MD m, Iride Dello Iacono, MD n, Andrea Di Rienzo Businco, MD o, Marcella Gallucci, MD p, Arianna Giannetti, MD q, Viviana Moschese, MD j, Elena Varin, MD r, Annamaria Bianchi, MD s, Mauro Calvani, MD s, Tullio Frediani, MD l, Francesco Macrì, MD l, Nunzia Maiello, MD m, Francesco Paravati, MD t, Umberto Pelosi, MD u, Diego Peroni, MD v, Giuseppe Pingitore, MD w, Mariangela Tosca, MD x, Anna Maria Zicari, MD l, Giampaolo Ricci, MD p, Riccardo Asero, MD y, Salvatore Tripodi, MD o
for the

Italian Pediatric Allergy Network

a Charité–Universitätsmedizin Berlin, a corporate member of Freie Universität Berlin and Humboldt–Universität zu Berlin, the Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Berlin, Germany 
b Institute of Allergology, Charité-Universitätsmedizin Berlin, Berlin, Germany 
c Department of Allergology and Immunology, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Berlin, Germany 
d Consultancy & Training, Biostatistics, L’altrastatistica, Rome, Italy 
e Thermo Fisher Scientific, Uppsala, Sweden 
f Clinical and Laboratory Molecular Allergy Unit, IDI-IRCCS, Rome, Italy 
g Pediatric Unit, San Giuseppe Hospital, Empoli, Italy 
h Department of Medicine and Surgery, Clinica Pediatrica, University of Parma, Parma, Italy 
i Pediatra di Libera Scelta, Benevento, Italy 
j UOSD di Immunopatologia ed Allergologia Pediatrica, Policlinico Tor Vergata, Università di Roma Tor Vergata, Rome, Italy 
k Department of Clinical and Experimental Medicine, Section of Paediatrics, University of Pisa, Pisa, Italy 
l Pediatric Department, La Sapienza University, Rome, Italy 
m Dipartimento della Donna, del Bambino e di Chirurgia Generale e Specialistica, Università della Campania Luigi Vanvitelli, Naples, Italy 
n Pediatric Unit, Fatebenefratelli Hospital, Benevento, Italy 
o Pediatric Department and Pediatric Allergology Unit, Sandro Pertini Hospital, Rome, Italy 
p Pediatric Unit, IRCCS Azienda Ospedaliero, Universitaria di Bologna, Bologna, Italy 
q Pediatric Intermediate Care Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy 
r Allergology Service, San Carlo Clinic, Paderno Dugnano, Milan, Italy 
s Pediatric Unit, San Camillo Forlanini Hospital, Rome, Italy 
t Pediatric Unit, ASL Crotone, Crotone, Italy 
u Pediatric Unit, Santa Barbara Hospital, Iglesias, Italy 
v Pediatric Section, Department of Life and Reproduction Sciences, University of Verona, Verona, Italy 
w Pediatric Unit, Grassi Hospital, Rome, Italy 
x Pulmonary Disease and Allergy Unit, G. Gaslini Hospital, Genoa, Italy 
y Ambulatorio di Allergologia, Clinica San Carlo, Paderno Dugnano, Italy 

Corresponding author: Paolo M. Matricardi, MD, Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité–Universitätsmedizin Berlin, Augustenburgerplatz, 1, 13353 Berlin, Germany.Department of Pediatric Respiratory MedicineImmunology and Critical Care MedicineCharité–Universitätsmedizin BerlinAugustenburgerplatz1Berlin13353Germany

Graphical abstract




Le texte complet de cet article est disponible en PDF.

Abstract

Background

Cyclophilins are ubiquitous panallergens whose epidemiologic, diagnostic, and clinical relevance is largely unknown and whose sensitization is rarely examined in routine allergy practice.

Objective

We investigated the epidemiologic, diagnostic, and clinical relevance of cyclophilins in seasonal allergic rhinitis and its comorbidities.

Methods

We examined a random sample of 253 (25%) of 1263 Italian children with seasonal allergic rhinitis from the Panallergens in Pediatrics (PAN-PED) cohort with characterized disease phenotypes. Nested studies of sensitization prevalence, correlation, and allergen extract inhibition were performed in patients sensitized to birch pollen extract but lacking IgE to Bet v 1/2/4 (74/1263) or with highest serum level of IgE to Bet v 1 (26/1263); and in patients with sensitization to various extracts (ragweed, mugwort, pellitory, Plantago, and plane tree), but not to their respective major allergenic molecule, profilins, and polcalcins. IgE to cyclophilin was detected with recombinant Bet v 7, and extract inhibition tests were performed with the same rBet v 7.

Results

IgE to rBet v 7 was detected in 43 (17%) of 253 patients. It was associated with asthma (P < .028) and oral allergy syndrome (P < .017) in univariate but not multivariate analysis adjusted for IgE to profilins (Phl p 12), PR-10s (Bet v 1), and lipid transfer proteins (Pru p 3). IgE to rBet v 7 was also highly prevalent (47/74, 63%) among patients with unexplained sensitization to birch pollen extract. In patients with unexplained sensitization to ragweed, mugwort, pellitory, Plantago and plane tree pollen, the levels of IgE to those extracts correlated with the levels of IgE to rBet v 7, and they were also significantly inhibited by rBet v 7 (inhibition range 45%-74%).

Conclusions

IgE sensitization to cyclophilin is frequent in pollen-allergic patients living in temperate areas and can produce “false” positive outcomes in skin prick and IgE tests to pollen extracts. Molecular diagnostic guidelines should include this panallergen family.

Le texte complet de cet article est disponible en PDF.

Key words : Allergic rhinitis, allergy, asthma, component resolved diagnostics, cross-reactivity, cyclophilins, diagnosis, immunoglobulin E, oral allergy syndrome, panallergens, pollen, precision medicine

Abbreviations used : AIT, CCD, Cyp, nsLTP, OAS, PAN-PED, PR-10, rBet v 7, SAR, sIgE, SPT


Plan


© 2024  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 153 - N° 6

P. 1586 - juin 2024 Retour au numéro
Article précédent Article précédent
  • Nasopharyngeal microbiota in children is associated with severe asthma exacerbations
  • Gina J. van Beveren, Wouter A.A. de Steenhuijsen Piters, Shelley A. Boeschoten, Sam Louman, Mei Ling Chu, Kayleigh Arp, Pieter L. Fraaij, Matthijs de Hoog, Corinne Buysse, Marlies A. van Houten, Elisabeth A.M. Sanders, Peter J.F.M. Merkus, Annemie L. Boehmer, Debby Bogaert
| Article suivant Article suivant
  • Early skin inflammatory biomarker is predictive of development and persistence of atopic dermatitis in infants
  • Georgios N. Stamatas, Takahiro Sato, Carol Ní Chaoimh, Thierry Oddos, Richard Insel, Jonathan O’B. Hourihane, Alan D. Irvine

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.